Hopes, and a Stock, Plunge on Failure of Alzheimer’s Drug
Wednesday, March 3, 2010 - 12:42
in Health & Medicine
The drug, called Dimebon, failed in its first late-stage clinical trial, dealing a blow to patients with Alzheimer’s and the companies developing the treatment, Medivation and Pfizer.